HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increasing cancer-specific gene expression by targeting overexpressed α5β1 integrin and upregulated transcriptional activity of NF-κB.

Abstract
We developed a modular multifunctional nonviral gene delivery system by targeting the overexpressed cancer surface receptor α5β1 integrin and the upregulated transcriptional activity of the cancer resistance mediating transcription factor NF-κB, thereby introducing a new form of transcriptional targeting. NF-κB regulated therapy can improve specificity of gene expression in cancer tissue and also may offset NF-κB mediated cancer resistance. We delivered a luciferase gene under the control of an NF-κB responsive element (pNF-κB-Luc) encapsulated in a PR_b peptide functionalized stealth liposome that specifically targets the α5β1 integrin and achieved increased gene expression in DLD-1 colorectal cancer cells compared to BJ-fibroblast healthy cells in vitro. The multitargeted system was also able to differentiate between cancer cells and healthy cells better than either of the individually targeted systems. In addition, we constructed a novel cancer therapeutic plasmid by cloning a highly potent diphtheria toxin fragment A (DTA) expressing gene under the control of an NF-κB responsive element (pNF-κB-DTA). A dose-dependent reduction of cellular protein expression and increased cytotoxicity in cancer cells was seen when transfected with PR_b functionalized stealth liposomes encapsulating the condensed pNF-κB-DTA plasmid. Our therapeutic delivery system specifically eradicated close to 70% of a variety of cancer cells while minimally affecting healthy cells in vitro. Furthermore, the modular nature of the nonviral design allows targeting novel pairs of extracellular receptors and upregulated transcription factors for applications beyond cancer gene therapy.
AuthorsMaroof M Adil, Rachel M Levine, Efrosini Kokkoli
JournalMolecular pharmaceutics (Mol Pharm) Vol. 11 Issue 3 Pg. 849-58 (Mar 03 2014) ISSN: 1543-8392 [Electronic] United States
PMID24483950 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Diphtheria Toxin
  • Integrin alpha5beta1
  • Liposomes
  • NF-kappa B
  • Peptide Fragments
  • RNA, Messenger
  • diphtheria toxin fragment A
  • Luciferases
Topics
  • Cell Proliferation
  • Cells, Cultured
  • Colorectal Neoplasms (genetics, pathology, prevention & control)
  • Diphtheria Toxin (genetics, metabolism)
  • Fibroblasts (cytology, metabolism)
  • Gene Expression Regulation, Neoplastic
  • Gene Transfer Techniques
  • Humans
  • Integrin alpha5beta1 (genetics, metabolism)
  • Liposomes
  • Luciferases (genetics, metabolism)
  • NF-kappa B (genetics, metabolism)
  • Peptide Fragments (administration & dosage, genetics, metabolism)
  • Plasmids (administration & dosage)
  • RNA, Messenger (genetics)
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcriptional Activation
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: